Finance

Lists
6FN:FRA
Klaria Pharma Holding AB (publ)
€0.050
-3.47%
(-0.0018) 1D
Sep 7, 8:07:48 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6FN...
Open
€0.05
High
€0.05
Low
€0.05
Mkt. cap
149.55M
Avg. vol.
33.00
Volume
0.00
52-wk high
€0.12
52-wk low
€0.03
No. of employees
4
Open
€0.05
High
€0.05
Low
€0.05
Mkt. cap
149.55M
Avg. vol.
33.00
Volume
0.00
52-wk high
€0.12
52-wk low
€0.03
No. of employees
4
About Klaria Pharma Holding AB (publ)
CEO-
Employees4
Founded2014
Headquarters-
SectorPharmaceutical industry
Websiteklaria.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
100.00K
10.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.75M
13.04M
4.91M
4.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.88M
2.24M
2.39M
6.34M
Operating expense
6.64M
15.28M
7.31M
10.75M
Total operating expenses
6.64M
15.28M
7.31M
10.75M
Operating income
-6.64M
-15.28M
-7.21M
-10.74M
Other non operating income
42.00K
-45.00K
1.00K
-
EBT including unusual items
-8.73M
-16.62M
-8.66M
-12.89M
EBT excluding unusual items
-8.73M
-16.62M
-8.66M
-12.89M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.73M
-16.62M
-8.66M
-12.89M
Net profit margin
-
-
-8,655.00%
-128,870.00%
Earnings per share
-
-
-
-
Interest and investment income
-
2.00K
-
-
Interest expense
-2.14M
-1.24M
-1.45M
-2.14M
Net interest expenses
-2.14M
-1.24M
-1.45M
-2.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.63M
-13.37M
-4.59M
-8.13M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps